Environmental Biotechnology is an interdisciplinary field that harnesses biological processes and organisms to address environmental challenges. This branch of biotechnology focuses on sustainable solutions for pollution control, waste treatment, and environmental restoration. Microorganisms, enzymes, and plants are employed to degrade pollutants, remediate contaminated sites, and convert waste into valuable resources.
Innovations in environmental biotechnology contribute to sustainable practices by minimizing the environmental impact of various industries. Bioremediation techniques, such as microbial degradation of pollutants, offer eco-friendly alternatives to conventional clean-up methods. Additionally, wastewater treatment using biological processes helps purify water for reuse, promoting conservation. This field plays a vital role in addressing global environmental issues, emphasizing the use of biological agents to create a cleaner and healthier planet. Advancements in genetic engineering and synthetic biology further enhance the efficiency of environmental biotechnological applications, making it a pivotal force in promoting ecological sustainability.
One key aspect of environmental biotechnology is the use of microorganisms, such as bacteria and fungi, to degrade pollutants and contaminants. This approach, known as bioremediation, plays a crucial role in cleaning up polluted environments, including soil and water systems.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia